{{Rsnum
|rsid=11055786
|Chromosome=12
|Orientation=plus
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=NANOG
|position=7792788
|Gene_s=NANOG
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 36.3 | 54.9 | 8.8
| HCB | 0.0 | 11.7 | 88.3
| JPT | 0.0 | 13.4 | 86.6
| YRI | 10.2 | 44.2 | 45.6
| ASW | 8.8 | 63.2 | 28.1
| CHB | 0.0 | 11.7 | 88.3
| CHD | 0.0 | 6.4 | 93.6
| GIH | 28.7 | 54.5 | 16.8
| LWK | 16.4 | 38.2 | 45.5
| MEX | 20.7 | 58.6 | 20.7
| MKK | 10.9 | 51.3 | 37.8
| TSI | 38.2 | 47.1 | 14.7
| HapMapRevision=28
}}{{PMID Auto
|PMID=25223935
|Title=Significant association of combination of OCT4, NANOG, and SOX2 gene polymorphisms in susceptibility and response to treatment in North Indian breast cancer patients
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}